Thermo Fisher Scientific Inc. (TMO): Price and Financial Metrics


Thermo Fisher Scientific Inc. (TMO): $584.09

-4.07 (-0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TMO POWR Grades


  • Sentiment is the dimension where TMO ranks best; there it ranks ahead of 83.18% of US stocks.
  • TMO's strongest trending metric is Growth; it's been moving down over the last 161 days.
  • TMO's current lowest rank is in the Momentum metric (where it is better than 27.95% of US stocks).

TMO Stock Summary

  • Thermo Fisher Scientific Inc's market capitalization of $232,527,776,139 is ahead of 99.23% of US-listed equities.
  • Thermo Fisher Scientific Inc's stock had its IPO on September 1, 1987, making it an older stock than 91.43% of US equities in our set.
  • As for revenue growth, note that TMO's revenue has grown 37.06% over the past 12 months; that beats the revenue growth of 78.91% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Thermo Fisher Scientific Inc are CMCSA, ABT, NKE, PEP, and NVO.
  • Visit TMO's SEC page to see the company's official filings. To visit the company's web site, go to www.thermofisher.com.

TMO Valuation Summary

  • In comparison to the median Healthcare stock, TMO's EV/EBIT ratio is 24.91% lower, now standing at 22.
  • TMO's EV/EBIT ratio has moved down 79.8 over the prior 243 months.
  • Over the past 243 months, TMO's price/sales ratio has gone up 3.9.

Below are key valuation metrics over time for TMO.

Stock Date P/S P/B P/E EV/EBIT
TMO 2021-08-31 5.7 5.9 25.4 22.0
TMO 2021-08-30 5.7 6.0 25.6 22.1
TMO 2021-08-27 5.6 5.9 25.1 21.7
TMO 2021-08-26 5.7 5.9 25.3 21.9
TMO 2021-08-25 5.6 5.9 25.1 21.7
TMO 2021-08-24 5.7 5.9 25.2 21.8

TMO Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 213.79%.
  • Its 2 year price growth rate is now at 57%.
  • The 5 year price growth rate now stands at 124.41%.
TMO's revenue has moved up $12,811,000,000 over the prior 15 months.

The table below shows TMO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 39,059 10,194 8,565
2021-06-30 38,250 10,252 8,596
2021-03-31 35,894 9,911 7,924
2020-12-31 32,218 8,289 6,375
2020-09-30 28,497 6,863 4,879
2020-06-30 26,248 5,272 3,706

TMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TMO has a Quality Grade of C, ranking ahead of 62.66% of graded US stocks.
  • TMO's asset turnover comes in at 0.574 -- ranking 43rd of 75 Measuring and Control Equipment stocks.
  • PACB, PKI, and PRPO are the stocks whose asset turnover ratios are most correlated with TMO.

The table below shows TMO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.574 0.513 0.323
2021-04-03 0.551 0.515 0.302
2020-12-31 0.509 0.497 0.244
2020-09-26 0.470 0.473 0.209
2020-06-27 0.446 0.454 0.166
2020-03-28 0.443 0.443 0.174

TMO Price Target

For more insight on analysts targets of TMO, see our TMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $586.74 Average Broker Recommendation 1.36 (Strong Buy)

TMO Stock Price Chart Interactive Chart >

Price chart for TMO

TMO Price/Volume Stats

Current price $584.09 52-week high $672.34
Prev. close $588.16 52-week low $433.52
Day low $578.28 Volume 789,993
Day high $590.53 Avg. volume 1,885,821
50-day MA $632.85 Dividend yield 0.18%
200-day MA $555.06 Market Cap 230.16B

Thermo Fisher Scientific Inc. (TMO) Company Bio


Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. (Source:Wikipedia)


TMO Latest News Stream


Event/Time News Detail
Loading, please wait...

TMO Latest Social Stream


Loading social stream, please wait...

View Full TMO Social Stream

Latest TMO News From Around the Web

Below are the latest news stories about Thermo Fisher Scientific Inc that investors may wish to consider to help them evaluate TMO as an investment opportunity.

10 Healthcare Stocks to Buy According to Billionaire DE Shaw

In this article, we discuss the 10 healthcare stocks to buy according to billionaire DE Shaw based on Q3 holdings of his fund. If you want to skip our detailed analysis of Shaw’s history, investment philosophy, and hedge fund performance, go directly to the 5 Healthcare Stocks to Buy According to Billionaire DE Shaw. David […]

Yahoo | January 17, 2022

M&A Boom Thunders On With KPN, Eutelsat Seen as Europe’s Top Targets

(Bloomberg) -- Telecom operators crowd dealmaking watch lists in Europe as the mergers and acquisitions boom shows no signs of slowing.Most Read from BloombergFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsMicrosoft Buys Scandal-Tainted Activision in Bet on MetaverseStock Selloff Deepens as Treasury Yields Climb: Markets WrapDeadly Drone Strikes on UAE Raise Gulf Tensions, Roil Oil MarketOlympic Ticket Sales Halted; Hong Kong Arrests: Virus UpdateRoyal KPN NV, whic

Yahoo | January 17, 2022

StrongBox Wealth, LLC Buys JPMorgan Equity Premium Income ETF, Nike Inc, Chevron Corp, Sells ...

Investment company StrongBox Wealth, LLC (Current Portfolio) buys JPMorgan Equity Premium Income ETF, Nike Inc, Chevron Corp, Vanguard Short-Term Inflation-Protected Securities, Kinder Morgan Inc, sells iShares Core U.S.

Yahoo | January 14, 2022

Here's Why You Should Retain Thermo Fisher (TMO) Stock for Now

Investors are optimistic about Thermo Fisher's (TMO) strong end-market growth and focus on international regions.

Yahoo | January 13, 2022

Thermo Fisher Scientific (TMO) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

No summary available.

Seeking Alpha | January 12, 2022

Read More 'TMO' Stories Here

TMO Price Returns

1-mo -10.37%
3-mo -4.52%
6-mo 9.83%
1-year 14.23%
3-year 144.38%
5-year 312.49%
YTD -12.46%
2021 43.54%
2020 43.72%
2019 45.55%
2018 18.21%
2017 35.03%

TMO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TMO Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8236 seconds.